Remove a-steadying-force-in-c-suite-the-changing-role-of-biopharma-cfos
article thumbnail

A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

PharmExec

COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.

69